evaluating next steps for tisotumab vedotin in recurrent or metastatic cervical cancer
Published 3 years ago • 510 plays • Length 1:24Download video MP4
Download video MP3
Similar videos
-
1:10
results for tisotumab vedotin in patients with metastatic or recurrent cervical cancer
-
4:44
safety and efficacy profile of tisotumab vedotin for recurrent or metastatic cervical cancer
-
4:58
tisotumab vedotin for metastatic cervical cancer: results from esmo 2023 with brian slomovitz, md
-
5:01
fda d.i.s.c.o. burst edition: fda approvals of tivdak (tisotumab vedotin-tftv) for recurrent or m...
-
0:55
dr. monk on the mechanism of action of tisotumab vedotin in recurrent cervical cancer
-
2:26
dr. krishnansu tewari on a phase iii trial exploring bevacizumab in recurrent cervical cancer
-
4:01
current settings for next-generation sequencing
-
0:57
dr. hong on the mechanism of action of tisotumab vedotin in cervical cancer
-
23:07
treatment of recurrent cervical cancer dr. shannon westin
-
1:45
dr. hong on the safety profile of tisatumab vedotin in cervical cancer
-
1:03:53
gynecologic oncology | year in review: clinical investigator perspectives on the most relevant ne...
-
8:52
frontline therapies for metastatic cervical cancer
-
59:38
new results on treatment of gynaecological cancers - european cancer congress (esmo) 2023
-
3:24
enfortumab vedotin as treatment for urothelial carcinomas
-
58:04
report back from sgo 2023: what’s new in cervical cancer?
-
7:46
expert report on novelties in the management of gynaecological malignancies from asco 2022
-
5:17
how to interpret results from next generation sequencing reports?
-
8:31
what tests are used to assess response to treatment?
-
4:06
the use of ctdna assays in patients with cancer